{"@context":{"@vocab":"https://schema.org/","dcterms":"http://purl.org/dc/terms/","prov":"http://www.w3.org/ns/prov#"},"@type":"ItemList","@id":"https://api.morvs.ai/api/v1/entity/BSX/timeline","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://api.morvs.ai/license","usage_info":"https://api.morvs.ai/license","rights":"Source-specific terms apply; free or keyless access does not alter them.","generated_at":"2026-11-01T09:11:17.313Z","methodology_url":"https://api.morvs.ai/datasets/","primary_sources":{"sec.*":"https://www.sec.gov/edgar","fda.*":"https://api.fda.gov/","contracts":"https://api.usaspending.gov/","clinical.trials":"https://clinicaltrials.gov/","lobbying.filings":"https://lda.senate.gov/","epa.facilities":"https://echo.epa.gov/","court.dockets":"https://www.courtlistener.com/","cfpb.complaints":"https://www.consumerfinance.gov/data-research/consumer-complaints/","nih.grants":"https://api.reporter.nih.gov/","fed.enforcement":"https://www.federalreserve.gov/supervisionreg/enforcementactions.htm","nhtsa.recalls":"https://api.nhtsa.gov/recalls/"}},"entity":{"entity_id":8451,"canonical_name":"BOSTON SCIENTIFIC CORP","cik":"0000885725","uei":null,"lei":null,"duns":null,"ticker":"BSX"},"window_days":365,"min_importance":0,"sources_queried":["sec.filings","sec.insider","sec.form144","sec.13dg","fda.recalls","fda.labels","contracts","clinical.trials","lobbying.filings","epa.facilities","uspto.patents","court.dockets","cfpb.complaints","nih.grants","fed.enforcement","nhtsa.recalls","doj.press","dol.form5500"],"importance_reference":{"fda.recall Class I":100,"clinical trial terminated":80,"securities class action":80,"antitrust suit":75,"schedule 13D":75,"patent litigation":70,"form144 large ($50M+)":75,"10-K restatement":75,"phase3 trial completed":70,"EPA significant violator":70,"phase3 trial in progress":60,"insider purchase":50,"phase2 trial":45,"8-K":35,"lobbying filing":30,"fda.label":30,"phase1 trial":30,"fda.recall Class III":25},"vertical_counts":{"sec":36,"court":9,"clinical":61,"fda":46},"count":100,"timeline":[{"ts":"2026-10-28","kind":"sec.filing","form_type":"8-K","title":"8-K — BOSTON SCIENTIFIC CORP — 2026-10-28","url_slug":"/sec/cik-0000885725/8-k/0000885725-26-000066","accession_number":"0000885725-26-000066","importance":35},{"ts":"2026-10-23","kind":"court.docket","reporter":"cacd","title":"Williams v. Boston Scientific Corporation","security_title":"365 Personal Inj. Prod. Liability","excerpt":"28:1332 Diversity-Product Liability","accession_number":"2:26-cv-12450","product_type":null,"importance":45},{"ts":"2026-10-22","kind":"court.docket","reporter":"cacd","title":"Rogers v. Boston Scientific Corporation","security_title":"365 Personal Inj. Prod. Liability","excerpt":"28:1332 Diversity-Personal Injury","accession_number":"2:26-cv-12364","product_type":null,"importance":45},{"ts":"2026-10-20","kind":"court.docket","reporter":"cacd","title":"Albright v. Boston Scientific Corporation","security_title":"365 Personal Inj. Prod. Liability","excerpt":"28:1332 Diversity-Product Liability","accession_number":"2:26-cv-12268","product_type":null,"importance":45},{"ts":"2026-10-20","kind":"court.docket","reporter":"cacd","title":"Bayhi v. Boston Scientific Corporation","security_title":"365 Personal Inj. Prod. Liability","excerpt":"28:1332 Diversity-Product Liability","accession_number":"2:26-cv-12269","product_type":null,"importance":45},{"ts":"2026-10-20","kind":"court.docket","reporter":"cacd","title":"Lamy v. Boston Scientific Corporation","security_title":"365 Personal Inj. Prod. Liability","excerpt":"28:1332 Diversity-Product Liability","accession_number":"2:26-cv-12271","product_type":null,"importance":45},{"ts":"2026-10-20","kind":"court.docket","reporter":"cacd","title":"Robinette v. Boston Scientific Corporation","security_title":"365 Personal Inj. Prod. Liability","excerpt":"28:1332 Diversity-Product Liability","accession_number":"2:26-cv-12272","product_type":null,"importance":45},{"ts":"2026-10-16","kind":"court.docket","reporter":"txsd","title":"James v. Boston Scientific Corporation","security_title":"367 Personal Injury: Health Care/Pharmaceutical Personal Injury Product Liability","excerpt":"28:1441 Petition for Removal- Personal Injury","accession_number":"4:26-cv-09149","product_type":null,"importance":45},{"ts":"2026-10-14","kind":"court.docket","reporter":"cacd","title":"Cooper v. Boston Scientific Corporation","security_title":"365 Personal Inj. Prod. Liability","excerpt":"28:1332 Diversity-Product Liability","accession_number":"2:26-cv-12020","product_type":null,"importance":45},{"ts":"2026-10-09","kind":"clinical.trial","reporter":"Boston Scientific Corporation","title":"An Optimization Study Evaluating Safety and Efficacy of the Y-90 Glioblastoma (GBM) Device in Patients With Recurrent GBM","security_title":"NA","status":"NOT_YET_RECRUITING","accession_number":"NCT07867886","excerpt":"[\"Recurrent Glioblastoma\"]","importance":25},{"ts":"2026-10-07","kind":"sec.filing","form_type":"8-K","title":"8-K — BOSTON SCIENTIFIC CORP — 2026-10-07","url_slug":"/sec/cik-0000885725/8-k/0000885725-26-000064","accession_number":"0000885725-26-000064","importance":35},{"ts":"2026-10-01","kind":"clinical.trial","reporter":"Boston Scientific Corporation","title":"A Post Approval Study to Evaluate Safety and Effectiveness of Multicompartmental Dosimetry Planning.","security_title":null,"status":"NOT_YET_RECRUITING","accession_number":"NCT07669727","excerpt":"[\"Hepatocellular Carcinoma (HCC)\"]","importance":25},{"ts":"2026-09-28","kind":"clinical.trial","reporter":"Boston Scientific Corporation","title":"A Global Randomized Trial Evaluating the FARAFLEX™ Mapping and Pulsed Field Ablation System With Electrographic Flow Mapping in Patients Undergoing Repeat Ablation for Atrial Fibrillation","security_title":"NA","status":"NOT_YET_RECRUITING","accession_number":"NCT07820930","excerpt":"[\"Atrial Fibrillation (AF)\",\"Persistent Atrial Fibrillation (PersAF)\",\"Paroxysmal Atrial Fibrillation (PAF)\"]","importance":25},{"ts":"2026-09-24","kind":"clinical.trial","reporter":"Boston Scientific Corporation","title":"Impact of Endoscopic Sleeve Gastroplasty (ESG) in Obese Adults With Type 2 Diabetes (T2D)","security_title":"NA","status":"NOT_YET_RECRUITING","accession_number":"NCT07639684","excerpt":"[\"Type 2 Diabetes Mellitus (T2D)\",\"Obesity (BMI>30)\"]","importance":25},{"ts":"2026-09-23","kind":"sec.filing","form_type":"8-K","title":"8-K — BOSTON SCIENTIFIC CORP — 2026-09-23","url_slug":"/sec/cik-0000885725/8-k/0000885725-26-000061","accession_number":"0000885725-26-000061","importance":35},{"ts":"2026-09-18","kind":"clinical.trial","reporter":"Boston Scientific Corporation","title":"Study of Eso-SPONGE for Treating Leaks After Upper Gastrointestinal Surgery","security_title":"NA","status":"NOT_YET_RECRUITING","accession_number":"NCT07711093","excerpt":"[\"Anastomotic Leaks\"]","importance":25},{"ts":"2026-09-10","kind":"fda.recall","reporter":"Boston Scientific Corporation","title":"Class II","security_title":"NaviFlex LW Pusher;  Advx Panc. Stent 4/5F;  Material Number (UPN): M00535030;","excerpt":"Device was incorrectly manufactured with a guidewire exit port (referred to in the IFU as the RX port), which is not a design feature associated with this device configuration.","accession_number":"Z-0143-2027","status":"Ongoing","product_type":"device","importance":60},{"ts":"2026-09-08","kind":"sec.filing","form_type":"8-K","title":"8-K — BOSTON SCIENTIFIC CORP — 2026-09-08","url_slug":"/sec/cik-0000885725/8-k/0000885725-26-000059","accession_number":"0000885725-26-000059","importance":35},{"ts":"2026-09-02","kind":"sec.insider.f","reporter":"O'Connor Padraig Andrew","title":"EVP, Global Operations","shares":567,"price_per_share":48.37,"usd_value":27426,"security_title":"Common Stock","importance":15.02742579},{"ts":"2026-09-02","kind":"sec.insider.m","reporter":"O'Connor Padraig Andrew","title":"EVP, Global Operations","shares":1171,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-08-26","kind":"sec.filing","form_type":"8-K","title":"8-K — BOSTON SCIENTIFIC CORP — 2026-08-26","url_slug":"/sec/cik-0000885725/8-k/0000885725-26-000056","accession_number":"0000885725-26-000056","importance":35},{"ts":"2026-08-25","kind":"sec.insider.p","reporter":"Morano Susan E","title":null,"shares":2040,"price_per_share":49.2195,"usd_value":100408,"security_title":"Common Stock","importance":50.10040778},{"ts":"2026-08-24","kind":"fda.recall","reporter":"Boston Scientific Corporation","title":"Class I","security_title":"Imager II Angiographic Catheters    M001314001  IMAGER II/5/ST/65/038 BX5;    M001314011  IMAGER II/5/ST/100/038 BX5;    M001314021  IMAGER II/5/ST/65/035 BX 5;    M001314031  IMAGER II/5/ST/100/035 BX 5;    M001314041  IMAGER II/5/BARNH/100/038 BX5;    M001314051  IMAGER II/5/BERN/100/038 BX5;    M001314061  IMAGER II/5/BERN/100/035 BX 5;    M001314081  IMAGER II/5/BERN/40/038 BX5;    M001314101  IMAGER II/5/BERN/65/038 BX5;    M001314141  IMAGER II/5/H1/100/038 BX5;    M001314151  IMAGER II/5/H1/100/035 BX 5;    M001314301  IMAGER II/5/SIM1/65/038 BX5;    M001314321  IMAGER II/5/SIM1/100/038 BX5;    M001314341  IMAGER II/5/SIM2/100/038 BX5;    M001314351  IMAGER II/5/SIM2/100/035 BX 5;    M001314361  IMAGER II/5/SIM3/100/038 BX5;    M001314521  IMAGER II/5/CHGB/65/038 BX5;    M001314581  IMAGER II/5/CONTRA 2/65/038 BX5;    M001314621  IMAGER II/5/C1/65/038 BX5;    M001314661  00AGER II/5/C2/65/038 BX5;    M001314671  IMAGER II/5/C2/65/035 BX 5;    M001314761  IMAGER II/5/MIK/65/038 BX5;    M001314771  IMAGER II/5/MIK/65/035 BX 5;    M001314821  IMAGER II/5/SHK1.0/65/038 BX5;    M001314861  IMAGER II/5/RC2/65/038 BX5;    M001314881  IMAGER II/5/RDC/65/038 BX5","excerpt":"Tip may fracture or detach, leading to device fragments remaining within the patient or migrating through the vasculature. Patient impact may include prolonged procedure or life-threatening embolism.","accession_number":"Z-3214-2026","status":"Ongoing","product_type":"device","importance":100},{"ts":"2026-08-11","kind":"sec.insider.i","reporter":"Woodworth Emily","title":"SVP, Global Controller and CAO","shares":2930,"price_per_share":51.19,"usd_value":149987,"security_title":"Common Stock","importance":15.1499867},{"ts":"2026-08-10","kind":"sec.insider.i","reporter":"Monson Jonathan","title":"EVP and CFO","shares":9908,"price_per_share":50.46,"usd_value":499958,"security_title":"Common Stock","importance":15.49995768},{"ts":"2026-08-06","kind":"fda.recall","reporter":"Boston Scientific Corporation","title":"Class II","security_title":"LUX-Dx, LUX-Dx II, LUX-Dx II+ Insertable Cardiac Monitor System, SERVER SW LAT CLARITY DS US, Model Number 7260, All Versions (Current 7.8)","excerpt":"There is potential for a delay in AF Burden Alert notification affecting the server software which supports the Insertable Cardiac Monitors (ICMs). Delayed notification of an AF Burden Alert may delay clinical evaluation or therapeutic intervention of an atrial arrhythmia.","accession_number":"Z-3081-2026","status":"Ongoing","product_type":"device","importance":60},{"ts":"2026-08-06","kind":"fda.recall","reporter":"Boston Scientific Corporation","title":"Class II","security_title":"LUX-Dx, LUX-Dx II, LUX-Dx II+ Insertable Cardiac Monitor System, SERVER SW LAT CLARITY DS ANZ, Model Number 7248, All Versions (Current 7.7)","excerpt":"There is potential for a delay in AF Burden Alert notification affecting the server software which supports the Insertable Cardiac Monitors (ICMs). Delayed notification of an AF Burden Alert may delay clinical evaluation or therapeutic intervention of an atrial arrhythmia.","accession_number":"Z-3083-2026","status":"Ongoing","product_type":"device","importance":60},{"ts":"2026-08-06","kind":"fda.recall","reporter":"Boston Scientific Corporation","title":"Class II","security_title":"LUX-Dx, LUX-Dx II, LUX-Dx II+ Insertable Cardiac Monitor System, SERVER SW LAT CLARITY DS EU, Model Number 7246, All Versions (Current 7.7)","excerpt":"There is potential for a delay in AF Burden Alert notification affecting the server software which supports the Insertable Cardiac Monitors (ICMs). Delayed notification of an AF Burden Alert may delay clinical evaluation or therapeutic intervention of an atrial arrhythmia.","accession_number":"Z-3082-2026","status":"Ongoing","product_type":"device","importance":60},{"ts":"2026-08-05","kind":"sec.insider.p","reporter":"Habiger David C","title":null,"shares":2100,"price_per_share":47.589,"usd_value":99937,"security_title":"Common Stock","importance":50.0999369},{"ts":"2026-08-04","kind":"sec.insider.p","reporter":"Habiger David C","title":null,"shares":140,"price_per_share":48.5879,"usd_value":6802,"security_title":"Common Stock","importance":50.006802306},{"ts":"2026-08-03","kind":"sec.insider.p","reporter":"Mahoney Michael F","title":"Chairman, President & CEO","shares":186240,"price_per_share":48.3323,"usd_value":9001408,"security_title":"Common Stock","importance":59.001407552},{"ts":"2026-08-03","kind":"sec.insider.p","reporter":"Habiger David C","title":null,"shares":1042,"price_per_share":48.0655,"usd_value":50084,"security_title":"Common Stock","importance":50.050084251},{"ts":"2026-08-03","kind":"sec.filing","form_type":"10-Q","title":"10-Q — BOSTON SCIENTIFIC CORP — 2026-08-03","url_slug":"/sec/cik-0000885725/10-q/0000885725-26-000053","accession_number":"0000885725-26-000053","importance":45},{"ts":"2026-08-03","kind":"sec.insider.i","reporter":"Mahoney Michael F","title":"Chairman, President & CEO","shares":22119,"price_per_share":48.43,"usd_value":1071223,"security_title":"Common Stock","importance":16.07122317},{"ts":"2026-07-31","kind":"sec.insider.p","reporter":"LUDWIG EDWARD J","title":null,"shares":5000,"price_per_share":45.4799,"usd_value":227400,"security_title":"Common Stock","importance":50.2273995},{"ts":"2026-07-31","kind":"sec.insider.i","reporter":"Fitzgerald Joseph Michael","title":"EVP & Group Pres, Cardiology","shares":64198,"price_per_share":46.73,"usd_value":2999973,"security_title":"Common Stock","importance":17.999972539999998},{"ts":"2026-07-29","kind":"sec.filing","form_type":"8-K","title":"8-K — BOSTON SCIENTIFIC CORP — 2026-07-29","url_slug":"/sec/cik-0000885725/8-k/0000885725-26-000051","accession_number":"0000885725-26-000051","importance":35},{"ts":"2026-07-27","kind":"sec.filing","form_type":"8-K","title":"8-K — BOSTON SCIENTIFIC CORP — 2026-07-27","url_slug":"/sec/cik-0000885725/8-k/0000885725-26-000049","accession_number":"0000885725-26-000049","importance":35},{"ts":"2026-07-22","kind":"fda.recall","reporter":"Boston Scientific Corporation","title":"Class II","security_title":"Boston Scientific Corporation  StoneSmart Connect Console  Contents: (1) Power Cord, (1) Power Adaptor, (1)DVI Cable, (1) DVI to HDMI Cable, (1) DisplayPort Cable  REF: M0067933000, M006793300H0, M006793300R0, M006793300D0, M006793300Z0, M0067930000, M006793000R0","excerpt":"A subset of power adapters used with the connect console may exhibit higher-than-expected resistance in the electrical grounding path. As a result, the power adaptor may fail electrical safety testing during installation.","accession_number":"Z-3188-2026","status":"Ongoing","product_type":"device","importance":60},{"ts":"2026-07-14","kind":"fda.recall","reporter":"Boston Scientific Corporation","title":"Class II","security_title":"OverStitch Suture Cinch, 1pk. Endoscopic tissue approximation device.","excerpt":"Device may fail to deploy the cinch implant and/or fail to cut the suture as intended.","accession_number":"Z-2961-2026","status":"Ongoing","product_type":"device","importance":60},{"ts":"2026-07-14","kind":"fda.recall","reporter":"Boston Scientific Corporation","title":"Class II","security_title":"Suture Cinch   Long 1pk. \tEndoscopic tissue approximation device.","excerpt":"Device may fail to deploy the cinch implant and/or fail to cut the suture as intended.","accession_number":"Z-2962-2026","status":"Ongoing","product_type":"device","importance":60},{"ts":"2026-07-09","kind":"fda.recall","reporter":"Boston Scientific Corporation","title":"Class I","security_title":"Boston Scientific ENROUTE Transcarotid Neuroprotection System Plus,  Material Number SR-250-NPS; Percutaneous catheter","excerpt":"Potential for arterial sheath tip separation or partial tip separation during use.","accession_number":"Z-2978-2026","status":"Ongoing","product_type":"device","importance":100},{"ts":"2026-07-09","kind":"fda.recall","reporter":"Boston Scientific Corporation","title":"Class I","security_title":"Boston Scientific ENROUTE Transcarotid Neuroprotection System,  Material Number SR-200-NPS; Percutaneous catheter","excerpt":"Potential for arterial sheath tip separation or partial tip separation during use.","accession_number":"Z-2977-2026","status":"Ongoing","product_type":"device","importance":100},{"ts":"2026-07-01","kind":"sec.insider.f","reporter":"Monson Jonathan","title":"EVP and CFO","shares":1010,"price_per_share":43.06,"usd_value":43491,"security_title":"Common Stock","importance":15.0434906},{"ts":"2026-07-01","kind":"sec.insider.m","reporter":"Monson Jonathan","title":"EVP and CFO","shares":2087,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-06-30","kind":"fda.recall","reporter":"Boston Scientific Corporation","title":"Class II","security_title":"Rapid Refill Continuous Injection System, UPN M00566001","excerpt":"Devices contain recalled Medline Namic Angiographic Control Syringe with Rotating Adaptor. There is a risk of syringe loosening or disconnecting from the manifold, resulting in loose connection or complete disconnection. May lead to difficulty connecting syringe, inability to aspirate or inject properly, fluid leakage, or separation of the syringe from the system, potentially requiring device exchange and prolonging the procedure.","accession_number":"Z-2725-2026","status":"Ongoing","product_type":"device","importance":60},{"ts":"2026-06-24","kind":"sec.filing","form_type":"11-K","title":"11-K — BOSTON SCIENTIFIC CORP — 2026-06-24","url_slug":"/sec/cik-0000885725/11-k/0000885725-26-000046","accession_number":"0000885725-26-000046","importance":30},{"ts":"2026-06-19","kind":"fda.recall","reporter":"Boston Scientific Corporation","title":"Class II","security_title":"Boston Scientific TheraSphere 360 Y-90 Management Platform, Model Number M00139509001; Radiological Image Processing System.","excerpt":"Software anomaly occurs when a user adds one or more vials to the cart and subsequently returns to the Activity Calculator to modify one or more input. When a user modifies an input and selects \"Recalculate\",  the dose calculation is updated correctly; however, any vials that were previously added to the cart are not automatically updated to reflect the revised calculation.","accession_number":"Z-2771-2026","status":"Ongoing","product_type":"device","importance":60},{"ts":"2026-06-11","kind":"fda.recall","reporter":"Boston Scientific Corporation","title":"Class II","security_title":"FARADRIVE STEERABLE SHEATH CLEAR, used to facilitate access to the vasculature and into the chambers of the heart, Material Number 21M402, IFU Reference Number LBL1062","excerpt":"Boston Scientific's complaint investigations have identified that a subset of air ingress complaints are associated with hemostatic valve damage related to dilator insertion orientation during device preparation. Valve damage may result in air ingress, potential air embolism, and associated patient harm. This risk can be mitigated by inserting the dilator straight through the center of the valve and fully advancing it into the sheath body.","accession_number":"Z-2755-2026","status":"Ongoing","product_type":"device","importance":60},{"ts":"2026-06-11","kind":"fda.recall","reporter":"Boston Scientific Corporation","title":"Class II","security_title":"FARASTAR Ablation Generator EU, Pulsed Field Ablation Generator, Product ID 61M401; Percutaneous Cardiac Ablation Catheter","excerpt":"Boston Scientific is replacing specific FARASTAR PFA generators which have a configuration that is not compatible for use with the FARAPOINT PFA catheter.","accession_number":"Z-2753-2026","status":"Ongoing","product_type":"device","importance":60},{"ts":"2026-06-11","kind":"fda.recall","reporter":"Boston Scientific Corporation","title":"Class II","security_title":"FARASTAR Ablation Generator EU, Pulsed Field Ablation Generator, Product ID 61M401; Percutaneous Cardiac Ablation Catheter","excerpt":"Labeling discrepancy:  Devices distributed with Instructions For Use (IFU) did not include  FARAPOINT PFA catheter information.","accession_number":"Z-2750-2026","status":"Ongoing","product_type":"device","importance":60},{"ts":"2026-06-11","kind":"fda.recall","reporter":"Boston Scientific Corporation","title":"Class II","security_title":"FARASTAR Pulsed Field Ablation Generator, Product ID M004PFCE61M401; Percutaneous Cardiac Ablation Catheter","excerpt":"Labeling discrepancy:  Devices distributed with Instructions For Use (IFU) did not include  FARAPOINT PFA catheter information.","accession_number":"Z-2751-2026","status":"Ongoing","product_type":"device","importance":60},{"ts":"2026-06-11","kind":"fda.recall","reporter":"Boston Scientific Corporation","title":"Class II","security_title":"FARASTAR PFA Generator, Product ID M004PFCE61M460; Percutaneous Cardiac Ablation Catheter","excerpt":"Labeling discrepancy:  Devices distributed with Instructions For Use (IFU) did not include  FARAPOINT PFA catheter information.","accession_number":"Z-2752-2026","status":"Ongoing","product_type":"device","importance":60},{"ts":"2026-06-11","kind":"fda.recall","reporter":"Boston Scientific Corporation","title":"Class II","security_title":"FARADRIVE STEERABLE SHEATH CLEAR OUS, used to facilitate access to the vasculature and into the chambers of the heart, Material Number M004PFCE21M402, IFU Reference Number 51659727-01","excerpt":"Boston Scientific's complaint investigations have identified that a subset of air ingress complaints are associated with hemostatic valve damage related to dilator insertion orientation during device preparation. Valve damage may result in air ingress, potential air embolism, and associated patient harm. This risk can be mitigated by inserting the dilator straight through the center of the valve and fully advancing it into the sheath body.","accession_number":"Z-2757-2026","status":"Ongoing","product_type":"device","importance":60},{"ts":"2026-06-11","kind":"fda.recall","reporter":"Boston Scientific Corporation","title":"Class II","security_title":"FARADRIVE Steerable Sheath Clear IDE, used to facilitate access to the vasculature and into the chambers of the heart, Material Number 21C602, IFU Reference Number 51636751-01","excerpt":"Boston Scientific's complaint investigations have identified that a subset of air ingress complaints are associated with hemostatic valve damage related to dilator insertion orientation during device preparation. Valve damage may result in air ingress, potential air embolism, and associated patient harm. This risk can be mitigated by inserting the dilator straight through the center of the valve and fully advancing it into the sheath body.","accession_number":"Z-2754-2026","status":"Ongoing","product_type":"device","importance":60},{"ts":"2026-06-11","kind":"fda.recall","reporter":"Boston Scientific Corporation","title":"Class II","security_title":"FARADRIVE STEERABLE SHEATH (CLEAR) - US, used to facilitate access to the vasculature and into the chambers of the heart, Material Number M004PF21M402, IFU Reference Number 51654495-01","excerpt":"Boston Scientific's complaint investigations have identified that a subset of air ingress complaints are associated with hemostatic valve damage related to dilator insertion orientation during device preparation. Valve damage may result in air ingress, potential air embolism, and associated patient harm. This risk can be mitigated by inserting the dilator straight through the center of the valve and fully advancing it into the sheath body.","accession_number":"Z-2756-2026","status":"Ongoing","product_type":"device","importance":60},{"ts":"2026-05-28","kind":"sec.insider.g","reporter":"Mahoney Michael F","title":"Chairman, President & CEO","shares":386755,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-05-21","kind":"fda.recall","reporter":"Boston Scientific Corporation","title":"Class II","security_title":"CRE Pro Wireguided 12-15mm 240cm","excerpt":"Potential sterile breach of the pouches in which devices are packaged.","accession_number":"Z-2629-2026","status":"Ongoing","product_type":"device","importance":60},{"ts":"2026-05-21","kind":"fda.recall","reporter":"Boston Scientific Corporation","title":"Class II","security_title":"CRE Pro Wireguided 10-12mm 240cm","excerpt":"Potential sterile breach of the pouches in which devices are packaged.","accession_number":"Z-2628-2026","status":"Ongoing","product_type":"device","importance":60},{"ts":"2026-05-21","kind":"fda.recall","reporter":"Boston Scientific Corporation","title":"Class II","security_title":"CRE Pro Wireguided 15-18mm 240cm","excerpt":"Potential sterile breach of the pouches in which devices are packaged.","accession_number":"Z-2630-2026","status":"Ongoing","product_type":"device","importance":60},{"ts":"2026-05-21","kind":"fda.recall","reporter":"Boston Scientific Corporation","title":"Class II","security_title":"CRE Pro Wireguided 6-8mm 240cm","excerpt":"Potential sterile breach of the pouches in which devices are packaged.","accession_number":"Z-2626-2026","status":"Ongoing","product_type":"device","importance":60},{"ts":"2026-05-21","kind":"fda.recall","reporter":"Boston Scientific Corporation","title":"Class II","security_title":"CRE Wireguided 8-10mm 240cm","excerpt":"Potential sterile breach of the pouches in which devices are packaged.","accession_number":"Z-2633-2026","status":"Ongoing","product_type":"device","importance":60},{"ts":"2026-05-21","kind":"fda.recall","reporter":"Boston Scientific Corporation","title":"Class II","security_title":"CRE Wireguided 12-15mm 240cm","excerpt":"Potential sterile breach of the pouches in which devices are packaged.","accession_number":"Z-2635-2026","status":"Ongoing","product_type":"device","importance":60},{"ts":"2026-05-21","kind":"fda.recall","reporter":"Boston Scientific Corporation","title":"Class II","security_title":"CRE Wireguided 15-18mm 240cm","excerpt":"Potential sterile breach of the pouches in which devices are packaged.","accession_number":"Z-2636-2026","status":"Ongoing","product_type":"device","importance":60},{"ts":"2026-05-21","kind":"fda.recall","reporter":"Boston Scientific Corporation","title":"Class II","security_title":"CRE Wireguided 6-8mm 240cm","excerpt":"Potential sterile breach of the pouches in which devices are packaged.","accession_number":"Z-2632-2026","status":"Ongoing","product_type":"device","importance":60},{"ts":"2026-05-21","kind":"fda.recall","reporter":"Boston Scientific Corporation","title":"Class II","security_title":"CRE Wireguided 18-20mm 240cm","excerpt":"Potential sterile breach of the pouches in which devices are packaged.","accession_number":"Z-2637-2026","status":"Ongoing","product_type":"device","importance":60},{"ts":"2026-05-21","kind":"fda.recall","reporter":"Boston Scientific Corporation","title":"Class II","security_title":"CRE Pro Wireguided 8-10mm 240cm","excerpt":"Potential sterile breach of the pouches in which devices are packaged.","accession_number":"Z-2627-2026","status":"Ongoing","product_type":"device","importance":60},{"ts":"2026-05-21","kind":"fda.recall","reporter":"Boston Scientific Corporation","title":"Class II","security_title":"CRE Wireguided 10-12mm 240cm","excerpt":"Potential sterile breach of the pouches in which devices are packaged.","accession_number":"Z-2634-2026","status":"Ongoing","product_type":"device","importance":60},{"ts":"2026-05-21","kind":"fda.recall","reporter":"Boston Scientific Corporation","title":"Class II","security_title":"CRE Pro Wireguided 18-20mm 240cm","excerpt":"Potential sterile breach of the pouches in which devices are packaged.","accession_number":"Z-2631-2026","status":"Ongoing","product_type":"device","importance":60},{"ts":"2026-05-21","kind":"sec.filing","form_type":"4","title":"4 — Habiger David C — 2026-05-21","url_slug":"/sec/cik-0001326409/4/0001225208-26-005546","accession_number":"0001225208-26-005546","importance":30},{"ts":"2026-05-21","kind":"sec.filing","form_type":"SD","title":"SD — BOSTON SCIENTIFIC CORP — 2026-05-21","url_slug":"/sec/cik-0000885725/sd/0000885725-26-000043","accession_number":"0000885725-26-000043","importance":30},{"ts":"2026-05-20","kind":"sec.insider.p","reporter":"LUDWIG EDWARD J","title":null,"shares":3580,"price_per_share":56.68,"usd_value":202914,"security_title":"Common Stock","importance":50.2029144},{"ts":"2026-05-20","kind":"sec.insider.p","reporter":"Habiger David C","title":null,"shares":2250,"price_per_share":55.9195,"usd_value":125819,"security_title":"Common Stock","importance":50.125818875},{"ts":"2026-05-20","kind":"sec.insider.p","reporter":"Pegus Cheryl","title":null,"shares":1770,"price_per_share":56.49,"usd_value":99987,"security_title":"Common Stock","importance":50.0999873},{"ts":"2026-05-19","kind":"sec.insider.p","reporter":"Habiger David C","title":null,"shares":2200,"price_per_share":56.9451,"usd_value":125279,"security_title":"Common Stock","importance":50.12527922},{"ts":"2026-05-18","kind":"sec.filing","form_type":"8-K","title":"8-K — BOSTON SCIENTIFIC CORP — 2026-05-18","url_slug":"/sec/cik-0000885725/8-k/0000885725-26-000041","accession_number":"0000885725-26-000041","importance":35},{"ts":"2026-05-18","kind":"sec.filing","form_type":"8-K","title":"8-K — BOSTON SCIENTIFIC CORP — 2026-05-18","url_slug":"/sec/cik-0000885725/8-k/0000885725-26-000042","accession_number":"0000885725-26-000042","importance":35},{"ts":"2026-05-18","kind":"clinical.trial","reporter":"Boston Scientific Corporation","title":"Intracept Minimally-invasive PROcedure for VErtebrogenic Back Pain","security_title":null,"status":"RECRUITING","accession_number":"NCT06827262","excerpt":"[\"Chronic Low-back Pain\",\"Vertebrogenic Pain Syndrome\"]","importance":25},{"ts":"2026-05-14","kind":"clinical.trial","reporter":"Boston Scientific Corporation","title":"SIMPLAAFY Clinical Trial","security_title":"NA","status":"ACTIVE_NOT_RECRUITING","accession_number":"NCT06521463","excerpt":"[\"Atrial Fibrillation\",\"Stroke\",\"Bleeding\"]","importance":25},{"ts":"2026-05-14","kind":"clinical.trial","reporter":"Boston Scientific Corporation","title":"Fainting Detection And Early Warning In Syncope Evaluation Study (ARISE)","security_title":null,"status":"NOT_YET_RECRUITING","accession_number":"NCT07502599","excerpt":"[\"Orthostatic Hypotension\",\"Reflex Syncope\"]","importance":25},{"ts":"2026-05-14","kind":"clinical.trial","reporter":"Boston Scientific Corporation","title":"cOncomitant Left Atrial aPpendage Closure and Pulsed Field ablaTION-Asia","security_title":null,"status":"RECRUITING","accession_number":"NCT06686485","excerpt":"[\"Concomitant Procedures\",\"Atrial Fibrillation\",\"PFA\",\"LAAC\"]","importance":25},{"ts":"2026-05-13","kind":"clinical.trial","reporter":"Boston Scientific Corporation","title":"A DirEct to PatieNt Study in Chronic Pain","security_title":null,"status":"COMPLETED","accession_number":"NCT05515341","excerpt":"[\"Chronic Pain\"]","importance":25},{"ts":"2026-05-12","kind":"fda.recall","reporter":"Boston Scientific Corporation","title":"Class II","security_title":"Orca Single Use Air/Water and Suction Valves, Material Number (UPN) SUV-617-50; The Orca Air/Water Valve is intended to be used to control the air/water function on an endoscope during a GI (gastrointestinal) endoscopic procedure.","excerpt":"Boston Scientific is initiating a medical device removal of  Orca Sterile, Single Use Air/Water and Suction Valves due to a higher than anticipated occurrence of the suction button sticking.","accession_number":"Z-2413-2026","status":"Ongoing","product_type":"device","importance":60},{"ts":"2026-05-12","kind":"clinical.trial","reporter":"Boston Scientific Corporation","title":"IT Matters: The Erectile Restoration Registry","security_title":null,"status":"ENROLLING_BY_INVITATION","accession_number":"NCT04200937","excerpt":"[\"Erectile Dysfunction\"]","importance":25},{"ts":"2026-05-12","kind":"clinical.trial","reporter":"Boston Scientific Corporation","title":"Effectiveness of the SpaceOAR Vue System in Subjects With Prostate Cancer","security_title":"NA","status":"ACTIVE_NOT_RECRUITING","accession_number":"NCT04905069","excerpt":"[\"Prostate Cancer\"]","importance":25},{"ts":"2026-05-11","kind":"fda.recall","reporter":"Boston Scientific Corporation","title":"Class II","security_title":"Intera Oncology INTERA 3000 Hepatic Artery Infusion Pump, AP-0300H, implantable drug delivery device","excerpt":"There is the potential for leakage along the drug pathway from the pump through the end of the catheter.","accession_number":"Z-2580-2026","status":"Completed","product_type":"device","importance":60},{"ts":"2026-05-11","kind":"clinical.trial","reporter":"Boston Scientific Corporation","title":"Safety and Effectiveness of Agent Paclitaxel-Coated PTCA Balloon Catheter. (AGENT Japan SV)","security_title":"NA","status":"ACTIVE_NOT_RECRUITING","accession_number":"NCT04058990","excerpt":"[\"Coronary Artery Disease\"]","importance":25},{"ts":"2026-05-08","kind":"clinical.trial","reporter":"Boston Scientific Corporation","title":"OPTION-EMEA Clinical Trial","security_title":"NA","status":"NOT_YET_RECRUITING","accession_number":"NCT07349121","excerpt":"[\"Atrial Fibrillation (AF)\",\"Stroke Prevention in Patients With Atrial Fibrillation\",\"Left Atrial Appendage Closure\",\"Pulsed Field Ablation\",\"Atrial Fibrillation Ablation Procedure\",\"Concomitant Procedures\"]","importance":25},{"ts":"2026-05-08","kind":"clinical.trial","reporter":"Boston Scientific Corporation","title":"A Prospective, Multi-center Study to Evaluate Efficacy and Safety of BSJ020R in Treatment of AVF for Hemodialysis (RANGER AV Japan Study)","security_title":"NA","status":"ACTIVE_NOT_RECRUITING","accession_number":"NCT06639451","excerpt":"[\"Arteriovenous Fistula Stenosis\",\"Arteriovenous Fistula\",\"Vascular Access\"]","importance":25},{"ts":"2026-05-08","kind":"clinical.trial","reporter":"Boston Scientific Corporation","title":"Paresthesia-Free Fast-Acting Subperception (FAST) Study","security_title":"NA","status":"ACTIVE_NOT_RECRUITING","accession_number":"NCT04618471","excerpt":"[\"Chronic Pain\"]","importance":25},{"ts":"2026-05-07","kind":"clinical.trial","reporter":"Boston Scientific Corporation","title":"Boston Scientific Registry of Deep Brain Stimulation for Treatment of Essential Tremor (ET)","security_title":null,"status":"RECRUITING","accession_number":"NCT04032470","excerpt":"[\"Essential Tremor\"]","importance":25},{"ts":"2026-05-07","kind":"clinical.trial","reporter":"Boston Scientific Corporation","title":"AGENT DCB STANCE: Safety and Effectiveness Study of AGENT Drug-Coated Balloon Compared to Standard of Care Percutaneous Coronary Intervention (PCI) Treatment for de Novo Coronary Lesions","security_title":"NA","status":"RECRUITING","accession_number":"NCT06959524","excerpt":"[\"Coronary Arterial Disease (CAD)\",\"de Novo Lesions in Native Coronary Arteries\"]","importance":25},{"ts":"2026-05-07","kind":"clinical.trial","reporter":"Boston Scientific Corporation","title":"Endo-SPONGE for Treatment of Anastomotic or Hartmann's Stump Leakages in Lower Pelvic Area","security_title":"NA","status":"RECRUITING","accession_number":"NCT07035431","excerpt":"[\"Anastomotic Leaks\",\"Hartmanns Stump Leakage\"]","importance":25},{"ts":"2026-05-07","kind":"sec.insider.a","reporter":"LUDWIG EDWARD J","title":null,"shares":3800,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-05-07","kind":"sec.insider.a","reporter":"Habiger David C","title":null,"shares":3800,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-05-07","kind":"sec.insider.a","reporter":"Zane Ellen M","title":null,"shares":3800,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-05-07","kind":"sec.insider.a","reporter":"WICHMANN DAVID S","title":null,"shares":3800,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-05-06","kind":"clinical.trial","reporter":"Boston Scientific Corporation","title":"AXIOS™ Gastroenterostomy for Gastric Outlet Obstruction IDE","security_title":"NA","status":"SUSPENDED","accession_number":"NCT06174805","excerpt":"Sponsor Decision","importance":80},{"ts":"2026-05-06","kind":"clinical.trial","reporter":"Boston Scientific Corporation","title":"Patient Retrospective Outcomes (PRO)","security_title":null,"status":"RECRUITING","accession_number":"NCT01550575","excerpt":"[\"Chronic Pain\"]","importance":25},{"ts":"2026-05-05","kind":"clinical.trial","reporter":"Boston Scientific Corporation","title":"Evaluation of Novel Waveforms Delivered Using the FARAPULSE™ PFA System","security_title":"NA","status":"RECRUITING","accession_number":"NCT07444320","excerpt":"[\"Paroxysmal Atrial Fibrillation\",\"Persistent Atrial Fibrillation\"]","importance":25}]}